Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
UBS
Moodys
Express Scripts
McKinsey
Federal Trade Commission
AstraZeneca
Cipla
US Army
Medtronic

Generated: October 23, 2017

DrugPatentWatch Database Preview

Ciprofloxacin; ciprofloxacin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ciprofloxacin; ciprofloxacin hydrochloride and what is the scope of ciprofloxacin; ciprofloxacin hydrochloride freedom to operate?

Ciprofloxacin; ciprofloxacin hydrochloride
is the generic ingredient in two branded drugs marketed by Dr Reddys Labs Ltd, Actavis Labs Fl Inc, Sandoz, Anchen Pharms, Bayer Hlthcare, and Mylan Pharms Inc, and is included in seven NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for ciprofloxacin; ciprofloxacin hydrochloride. Five suppliers are listed for this compound.

Summary for Generic Name: ciprofloxacin; ciprofloxacin hydrochloride

US Patents:2
Tradenames:2
Applicants:6
NDAs:7
Drug Master File Entries: see list31
Suppliers / Packagers: see list5
Clinical Trials: see list2,456
Drug Prices:see low prices
DailyMed Link:ciprofloxacin; ciprofloxacin hydrochloride at DailyMed

Pharmacology for Ingredient: ciprofloxacin; ciprofloxacin hydrochloride

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anchen Pharms
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL078166-001Nov 27, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL077809-001Nov 30, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Hlthcare
CIPRO XR
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021473-002Aug 28, 2003DISCNNoNo► Subscribe► SubscribeY► Subscribe
Bayer Hlthcare
CIPRO XR
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021473-001Dec 13, 2002DISCNNoNo► Subscribe► SubscribeY► Subscribe
Actavis Labs Fl Inc
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL077417-001Nov 30, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL078183-002Mar 22, 2007ABRXNoYes► Subscribe► Subscribe► Subscribe
Sandoz
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL078712-001Dec 11, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL077701-001Mar 26, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL078183-001Mar 22, 2007ABRXNoYes► Subscribe► Subscribe► Subscribe
Anchen Pharms
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL078166-002Nov 27, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ciprofloxacin; ciprofloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare
CIPRO XR
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021473-001Dec 13, 2002► Subscribe► Subscribe
Bayer Hlthcare
CIPRO XR
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021473-002Aug 28, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
AstraZeneca
Covington
Healthtrust
Daiichi Sankyo
Baxter
Novartis
UBS
Merck
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot